SAN ANTONIO -- The American Association for Cancer Research, The Cancer Therapy & Research Center at The University of Texas Health Sciences Center at San Antonio, and Baylor College of Medicine will be hosting the 2013 CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 10-14, at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
The symposium provides news on state-of-the-art breast cancer research, including experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease.
View the scientific program here.
Press conferences will take place Wednesday, Dec. 11, at 7:30 a.m. CT and 12:30 p.m. CT; Thursday, Dec. 12, at 7:30 a.m. CT; and Friday, Dec. 13, at 7:30 a.m. CT.
A press kit containing releases and highlighted abstracts will be available Dec. 3. Research that will be highlighted in the press program includes:
- New results on long-term survival from the NeoALLTO trial;
- First results from the I-SPY2 trial;
- Results from the IBIS-II Prevention study;
- Insight into effect of PIK3CA mutations on response to neoadjuvant treatment;
- Impact of adding new agents to neoadjuvant therapies for triple-negative breast cancer;
- New drug combinations for metastatic breast cancer;
- Results of a trial evaluating benefits of loco-regional treatment for women with metastatic breast cancer;
- New insight into the benefits and harms of mammography; and
- HOPE study results assessing benefits of exercise for women with breast cancer treatment-related side effects.
Registration will be available to members of the media who provide credentials. For more information or to register for the meeting, please contact Lauren Riley at email@example.com or 215-446-7155 or Jeremy Moore at firstname.lastname@example.org or 215-446-7109.
The mission of the 2013 CTRC-AACR San Antonio Breast Cancer Symposium is to produce a unique and comprehensive scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for patients with breast cancer. The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, the American Association for Cancer Research (AACR) and Baylor College of Medicine are joint sponsors of the San Antonio Breast Cancer Symposium. This collaboration utilizes the clinical strengths of the CTRC and Baylor and the AACR's scientific prestige in basic, translational, and clinical cancer research to expedite the delivery of the latest scientific advances to the clinic. For more information about the symposium, please visit http://www.